Question

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

no comments0

Total Forecasters25

Community Prediction43% (35% - 50%)

Make a Prediction

50%

community: 43%

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Health & Pandemics

Food and Drug Administration

Ozempic’s Active Ingredient May Reduce Alcohol Cravings, Study Says

Forbes•Feb 13, 2025

Study suggests obesity drugs could help with alcohol cravings

PBS NewsHour•Feb 13, 2025

Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction

Time•Feb 13, 2025

Learn more about Metaculus NewsMatch

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments